These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8486826)

  • 1. Introduction to the gadolinium class.
    Brasch RC
    J Comput Assist Tomogr; 1993; 17 Suppl 1():S14-8. PubMed ID: 8486826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: a review.
    Kuriashkin IV; Losonsky JM
    Vet Radiol Ultrasound; 2000; 41(1):4-7. PubMed ID: 10695873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
    Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
    J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for multi-modality cancer diagnosis: Simple protocol for self-assembly of gold nanoclusters mediated by gadolinium ions.
    Hou W; Xia F; Alfranca G; Yan H; Zhi X; Liu Y; Peng C; Zhang C; de la Fuente JM; Cui D
    Biomaterials; 2017 Mar; 120():103-114. PubMed ID: 28049064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of paramagnetic agents by off-resonance rotating frame technique in the presence of magnetization transfer effect.
    Zhang H; Xie Y
    J Magn Reson; 2007 Feb; 184(2):275-91. PubMed ID: 17123851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents.
    Allen M; Bulte JW; Liepold L; Basu G; Zywicke HA; Frank JA; Young M; Douglas T
    Magn Reson Med; 2005 Oct; 54(4):807-12. PubMed ID: 16155869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast material-enhanced visualization of the ablation medium for magnetic resonance-monitored ethanol injection therapy: imaging and safety aspects.
    Nanz D; Andreisek G; Fröhlich JM; Weishaupt D; Treiber K; Ess S; Pfammatter T
    J Vasc Interv Radiol; 2006 Jan; 17(1):95-102. PubMed ID: 16415138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids.
    Jackson EF; Esparza-Coss E; Wen X; Ng CS; Daniel SL; Price RE; Rivera B; Charnsangavej C; Gelovani JG; Li C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):830-8. PubMed ID: 17379450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI contrast agents: Classification and application (Review).
    Xiao YD; Paudel R; Liu J; Ma C; Zhang ZS; Zhou SK
    Int J Mol Med; 2016 Nov; 38(5):1319-1326. PubMed ID: 27666161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of contrast enhancement in magnetic resonance imaging.
    Lee DH
    Can Assoc Radiol J; 1991 Feb; 42(1):6-12. PubMed ID: 2001531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging using gadolinium-based contrast agents.
    Mitsumori LM; Bhargava P; Essig M; Maki JH
    Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelates of gadolinium and dysprosium as contrast agents for MR imaging.
    Rocklage SM; Watson AD
    J Magn Reson Imaging; 1993; 3(1):167-78. PubMed ID: 8428084
    [No Abstract]   [Full Text] [Related]  

  • 18. Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).
    Querol M; Bogdanov A
    J Magn Reson Imaging; 2006 Nov; 24(5):971-82. PubMed ID: 17024658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications.
    de Sousa PL; Livramento JB; Helm L; Merbach AE; Même W; Doan BT; Beloeil JC; Prata MI; Santos AC; Geraldes CF; Tóth E
    Contrast Media Mol Imaging; 2008; 3(2):78-85. PubMed ID: 18412106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.